Ultragenyx Pharmaceutical Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC RARE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

204,107

Value ($000)

4,694

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	4,694	0.0%	204,107	12/31/2025
2025 Q3	11/14/2025	6,228	0.0%	207,042	9/30/2025
2025 Q2	8/14/2025	10,943	0.0%	300,962	6/30/2025
2025 Q1	5/19/2025	8,414	0.0%	232,360	3/31/2025
2024 Q4	2/14/2025	8,514	0.0%	202,376	12/31/2024
2024 Q3	11/14/2024	9,874	0.0%	177,756	9/30/2024
2024 Q2	8/14/2024	7,267	0.0%	176,809	6/30/2024
2024 Q1	5/15/2024	6,082	0.0%	130,260	3/31/2024
2023 Q4	2/14/2024	5,653	0.0%	118,206	12/31/2023
2023 Q3	11/13/2023	4,083	0.0%	114,521	9/30/2023
2023 Q2	8/11/2023	4,249	0.0%	105,967	6/30/2023
2023 Q1	5/15/2023	4,249	0.0%	105,967	3/31/2023
2022 Q4	2/14/2023	5,649	0.0%	121,919	12/31/2022
2022 Q3	11/14/2022	4,085	0.0%	98,637	9/30/2022
2022 Q2	8/12/2022	6,842	0.0%	114,676	6/30/2022
2022 Q1	5/16/2022	8,365	0.0%	115,183	3/31/2022
2021 Q4	2/14/2022	8,704	0.0%	103,514	12/31/2021
2021 Q3	11/15/2021	8,362	0.0%	92,713	9/30/2021
2021 Q2	8/16/2021	9,084	0.0%	95,271	6/30/2021
2021 Q1	5/14/2021	8,257	0.0%	72,517	3/31/2021
2020 Q4	3/1/2021	9,469	0.0%	68,401	12/31/2020
2020 Q3	11/13/2020	5,370	0.0%	65,335	9/30/2020
2020 Q2	8/14/2020	4,701	0.0%	60,098	6/30/2020
2020 Q1	5/15/2020	2,684	0.0%	60,408	3/31/2020
2019 Q4	2/14/2020	2,538	0.0%	59,420	12/31/2019